Zika testing: FDA authorizes Abbott molecular test for emergency use

Abbott announced Thursday that the U.S. Food and Drug Administration (FDA) has authorized its molecular test, the Abbott RealTime ZIKA test, to detect Zika virus in whole blood (when collected alongside a patient-matched serum or plasma sample) for emergency use. This is the first molecular test made by a commercial manufacturer authorized to detect Zika ["]

The post Zika testing: FDA authorizes Abbott molecular test for emergency use appeared first on Outbreak News Today.